Germany, BioNTech and vaccine
Digest more
The payment is the third instalment paid to Berlin from the fund and is meant to support "reforms for a more efficient and ...
In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German ...
The closed sites include some that came with its $1.25 billion takeover of CureVac last year, and BioNTech has said it hopes ...
BioNTech is planning site closures affecting up to 1,860 jobs and will buy back $1 billion in shares after announcing the ...
Germany's BioNTech said on Tuesday it would close sites affecting up to 1,860 jobs and buy back up to $1 billion worth of ...
Germany has vehemently dismissed accusations from US Health Secretary Robert F. Kennedy Jr., who claimed the nation had undermined patient autonomy, particularly throughout the COVID-19 pandemic.
BERLIN (AP) — The German government has sharply rejected accusations by U.S. Health Secretary Robert F. Kennedy Jr. claiming that it has been sidelining patient autonomy, especially during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results